Form 4 for BNTX BioNTech SE
Accepted 2026-09-22 17:04:20 ET · period of report 2026-09-21 · accession 0002123975-26-000021 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MT | 2026-09-22 17:04 | 2026-09-21+ | BNTX | Sahin Ugur | CEO, 10% | S - Sale | $99.50 | -79.0K | 410.2K | -16% | -$7.86M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2026-09-21 | S | D | 33,000 | $97.81 | 456,209 | D | — | — | |
| 2 | Common | Ordinary Shares | 2026-09-22 | S | D | 46,000 | $100.72 | 410,209 | D | — | — |